Daewoong pharmaceutical Co.,Ltd (069620.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2T |
| Enterprise Value | 2.66T |
| P/E Ratio | 6.42 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.77 |
| Price/Book Ratio | 1.19 |
| Enterprise/Revenue | 1.24 |
| Enterprise/EBITDA | 7.92 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 1.57T |
| Revenue/Share | 141,124.47 |
| Gross Profit | 812.85B |
| EBITDA | 245.78B |
| Net Income | 195.86B |
| Diluted EPS | 17,021 |
Balance Sheet
| Total Cash | 158.42B |
| Total Cash/Share | 13,672.04 |
| Total Debt | 925.02B |
| Total Debt/Equity | 0.87 |
| Current Ratio | 0.89 |
| Book Value Per Share | 102,829.03 |
Price History
| 52-Week Change | -17.61 |
| 52-Week High | 199,400 |
| 52-Week Low | 104,900 |
| Moving Average 50 Days | 118,440 |
| Moving Average 200 Days | 143,541.5 |
Statistics
| Average Volume | 32,221 |
| Shares Outstanding | 11.51M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 600 |
| Trailing Annual Dividend Yield | 0.55 |
| Payout Ratio | 0.05 |
| Last Split Factor | 103:100 |
| Last Split Date | December 27, 2012 |
AD
